Get startedLog in
    Picture of Novartis AG logo

    NOVN — Novartis AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    US FDA approves Scholar Rock's muscle weakness drug

    Picture of Novartis AG logoNovartis AG
    11/09/2026 22:24
    US FDA approves Scholar Rock's muscle weakness drug
    Sept 11 (Reuters) - The U.S. Food and Drug Administration on Friday approved Scholar Rock's SRRK.O therapy to treat a rare genetic condition that causes muscle weakness.


     (Reporting by Sneha S K in Bengaluru; Editing by Tasim Zahid)
     ((Sneha.SK@thomsonreuters.com;))

    Recent news on Novartis AG

    See all news